Related Experiment Video
Updated: Aug 1, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
Acute bleeding complications in patients after bone marrow transplantation
1Department of Oncology, The Bunting-Blaustein Building for Cancer Research, Baltimore, Maryland 21231-1000, USA. snevo@netvision.net.il
Acute bleeding after bone marrow transplantation is common and linked to lower survival rates. Monitoring all bleeding signs is crucial for identifying patients at risk for transplant toxicity.
Area of Science:
- Hematology
- Transplantation Medicine
- Oncology
Background:
- Acute bleeding is a frequent complication following bone marrow transplantation (BMT).
- While not always a direct cause of death, bleeding is associated with increased morbidity and reduced survival post-BMT.
- The pathogenesis of bleeding in BMT patients may involve factors beyond profound thrombocytopenia.
Purpose of the Study:
- To analyze the association between bleeding complications and survival outcomes in bone marrow transplant recipients.
- To investigate the relationship between bleeding intensity, number of bleeding sites, and patient survival.
- To evaluate the implications of changing prophylactic platelet transfusion triggers on bleeding incidence and other clinical parameters.
Main Methods:
- Retrospective analysis of bleeding events and patient outcomes after bone marrow transplantation.
- Correlation of bleeding intensity and number of bleeding sites with survival data.
- Review of prophylactic platelet transfusion practices and their impact on bleeding episodes.
Main Results:
- Bleeding from any site was associated with reduced survival, with reduced survival correlating with bleeding intensity and the number of bleeding sites.
- Most bleeding episodes occurred with platelet counts greater than 20 x 10(9)/L, suggesting multifactorial causes.
- A shift in prophylactic platelet transfusion triggers to 10 x 10(9)/L necessitates careful monitoring for unintended consequences.
Conclusions:
- Bleeding manifestations in bone marrow transplant patients are critical indicators of toxicity and prognosis.
- Comprehensive monitoring of all bleeding sites is essential for risk stratification.
- Changes in transfusion thresholds require vigilant assessment to ensure patient safety and optimize outcomes.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...

